Does Rallies show ZYBT price targets?

Yes. Rallies tracks ZYBT analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.

Is ZYBT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ZYBT. It does not provide personalized investment advice.

ZYBT (Zhengye Biotechnology Holding Limited Class A Ordinary Shares) Stock Analysis - Analyst Ratings

Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT) is a publicly traded Healthcare sector company. As of May 21, 2026, ZYBT trades at $0.88 with a market cap of $43.74M and a P/E ratio of 0.00. ZYBT moved +0.00% today. Year to date, ZYBT is -22.78%; over the trailing twelve months it is -88.54%. Its 52-week range spans $0.68 to $14.30. Rallies surfaces ZYBT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate ZYBT?

The average price target is $0.00.

ZYBT Key Metrics

Key financial metrics for ZYBT
Metric	Value
Price	$0.88
Market Cap	$43.74M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$14.30
52-Week Low	$0.68
Volume	0
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

ZYBT Analyst Consensus

ZYBT analyst coverage data. Average price target: $0.00.

Latest ZYBT News

Zhengye Biotechnology Sees 37.6% Revenue Drop to RMB116.4M, RMB83M Loss — Apr 28, 2026

Common questions about ZYBT

What do analysts rate ZYBT?: The average price target is $0.00.
Does Rallies show ZYBT price targets?: Yes. Rallies tracks ZYBT analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is ZYBT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ZYBT. It does not provide personalized investment advice.